Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» XOMA Receives Orphan Drug Designation From U.S. Food & Drug Administration for Gevokizumab
XOMA Receives Orphan Drug Designation From U.S. Food & Drug Administration for Gevokizumab
XOMA Receives Orphan Drug Designation From U.S. Food & Drug Administration for Gevokizumab
Submitted by
admin
on August 23, 2012 - 9:58am
Source:
Yahoo
News Tags:
Xoma
FDA
orphan drugs
gevokizumab
uveitis
Headline:
XOMA Receives Orphan Drug Designation From U.S. Food & Drug Administration for Gevokizumab
Do Not Allow Advertisers to Use My Personal information
